ReviewClinical and translational imaging2016
Methodological aspects of
Review in Clinical and translational imaging, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it.
- SNMMI Procedure Standard/EANM Practice Guideline for Molecular Breast Imaging with Dedicated γ-Cameras.Journal of nuclear medicine technology · 2022Guideline
- Current and future perspectives of molecular breast imaging with [European journal of nuclear medicine and molecular imaging · 2026Review
- Innovative Advances in Molecular Breast Imaging Biopsy.Radiology. Imaging cancer · 2024Article
- Breast-Specific Gamma Imaging with [Journal of clinical medicine · 2020Article
- Positive molecular breast imaging: challenges and problem solving with contrast-enhanced spectral mammography.BMJ case reports · 2019Article
- Response to neoadjuvant chemotherapy for breast cancer judged by PERCIST - multicenter study in Japan.European journal of nuclear medicine and molecular imaging · 2018Article
- The clinical impact of molecular breast imaging in women with proven invasive breast cancer scheduled for breast-conserving surgery.Breast cancer research and treatment · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis review aims to discuss the methodological aspects of dedicated molecular breast imaging (MBI) using
methodsLiterature search was performed using the PubMed/MEDLINE database and "
resultsThere are few studies on
conclusionsMBI-guided biopsy appears to be a complementary modality and is principally indicated in the case of occult or unclear breast lesions on MG/US, that are suspicious on MBI. The future indication is in targeted biopsies in patients with large heterogeneous tumours. Further studies are needed to define the accuracy of this biopsy procedure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.